CROI 2019 Program and Conference Information

Oral Sessions

Themed Discussion TD-05 THE MASKED MARVELS YOU DON’T WANT TO MEET: SYPHILIS AND LGV Room 6E 1:30 PM - 2:30 PM Themed Discussion Leader

Khalil G. Ghanem, Johns Hopkins University, Baltimore, MD, USA 1011 EFFECTIVE TREATMENT OF LYMPHOGRANULOMA PROCTITISWITH EXTENDED AZITHROMYCIN REGIMEN

José L. Blanco, Irene Fuertes, Jordi Bosch, Ana González-Cordón, Esteban Martinez, Andrea Vergara, Teresa Estrach, Jose M. Gatell, Alsina Merçe 1012 ADHERENCE OF HEALTH CARE PROVIDERS TO CDC LUMBAR- PUNCTURE CRITERIA AMONG SYPHILIS/HIV Barbara L. Henriques, Vivian I. Avelino-Silva, Marilia B. Antonio, Jose E. Vidal 1013 HEARING LOSS IN UNSELECTED INDIVIDUALSWITH SYPHILIS Meena Ramchandani, Jamie Litvack, Clare Maxwell, Lauren Tantalo, Sharon Sahi, Shelia Dunaway, Christina Marra 1014 COGNITIVE IMPAIRMENT IN INDIVIDUALSWITH SYPHILIS Kevin Robertson, Haley Mendoza, Clare Maxwell, Shelia Dunaway, Arielle P. Davis, Sharon Sahi, Lauren Tantalo, Jana Zahlan, Sheryl Storey, Christina Marra 1015 RESPONSE TO SYPHILIS TREATMENT: CDC GUIDELINES IN HIV-INFECTED ADULTS ON cART Melody Ren, Leah Szadkowski, Darrell H. Tan, Sharon Walmsley Symposium S-1 HIV-ASSOCIATED TUMOR VIRUSES: PARTNERS IN CRIME Room 6C 4:00 PM - 6:00 PM Target Audience: This session is directed both to clinicians treating HIV-infected individuals and basic scientists who study viral-host interactions. It is expected that this audience will recognize and have interest in the ongoing problem of HIV- associated cancers, particularly those caused by Kaposi sarcoma-associated herpes virus (KSHV), Epstein-Barr virus (EBV), human papilloma virus (HPV), and hepatitis B (HBV). Level of Knowledge: It is assumed that the participants will be familiar with the ongoing challenge of HIV-associated cancers, particularly KSHV, cervical and anal cancer, and lymphomas and liver cancer. Objectives: At the completion of the session, participants will be able to: • Describe the mechanisms and emerging concepts concerning the links between KSHV, HPV, EBV, and HBV and cancer • Describe how coinfection of these viruses with HIV is contributing to an ongoing epidemic of cancer in individuals living with HIV • Appreciate how a basic understanding of tumor viruses is leading to novel interventions to prevent infection or the development of the cancers these viruses cause CME

Oral Sessions • Tuesday

CROI 2019 39